These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15598563)

  • 1. Asymmetric synthesis and biological evaluation of the enantiomeric isomers of the immunosuppressive FTY720-phosphate.
    Kiuchi M; Adachi K; Tomatsu A; Chino M; Takeda S; Tanaka Y; Maeda Y; Sato N; Mitsutomi N; Sugahara K; Chiba K
    Bioorg Med Chem; 2005 Jan; 13(2):425-32. PubMed ID: 15598563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of 4(5)-phenylimidazole-based analogues of sphingosine-1-phosphate and FTY720: discovery of potent S1P1 receptor agonists.
    Clemens JJ; Davis MD; Lynch KR; Macdonald TL
    Bioorg Med Chem Lett; 2005 Aug; 15(15):3568-72. PubMed ID: 15982878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus.
    Chiba K; Matsuyuki H; Maeda Y; Sugahara K
    Cell Mol Immunol; 2006 Feb; 3(1):11-9. PubMed ID: 16549044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors.
    Chiba K
    Pharmacol Ther; 2005 Dec; 108(3):308-19. PubMed ID: 15951022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S1P receptor mediated activity of FTY720 phosphate mimics.
    Högenauer K; Hinterding K; Nussbaumer P
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1485-7. PubMed ID: 20153186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent S1P receptor agonists replicate the pharmacologic actions of the novel immune modulator FTY720.
    Hale JJ; Neway W; Mills SG; Hajdu R; Ann Keohane C; Rosenbach M; Milligan J; Shei GJ; Chrebet G; Bergstrom J; Card D; Koo GC; Koprak SL; Jackson JJ; Rosen H; Mandala S
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3351-5. PubMed ID: 15149705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FTY720 inhibits S1P-mediated endothelial healing: relationship to S1P1-receptor surface expression.
    Krump-Konvalinkova V; Chwalla I; Siess W
    Biochem Biophys Res Commun; 2008 Jun; 370(4):603-8. PubMed ID: 18402775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.
    Lan YY; Tokita D; Wang Z; Wang HC; Zhan J; Brinkmann V; Thomson AW
    Transpl Immunol; 2008 Nov; 20(1-2):88-94. PubMed ID: 18694829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, stereochemical determination and biochemical characterization of the enantiomeric phosphate esters of the novel immunosuppressive agent FTY720.
    Hale JJ; Yan L; Neway WE; Hajdu R; Bergstrom JD; Milligan JA; Shei GJ; Chrebet GL; Thornton RA; Card D; Rosenbach M; HughRosen ; Mandala S
    Bioorg Med Chem; 2004 Sep; 12(18):4803-7. PubMed ID: 15336258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization.
    LaMontagne K; Littlewood-Evans A; Schnell C; O'Reilly T; Wyder L; Sanchez T; Probst B; Butler J; Wood A; Liau G; Billy E; Theuer A; Hla T; Wood J
    Cancer Res; 2006 Jan; 66(1):221-31. PubMed ID: 16397235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The S1P receptor modulator FTY720 prevents the development of experimental colitis in mice.
    Deguchi Y; Andoh A; Yagi Y; Bamba S; Inatomi O; Tsujikawa T; Fujiyama Y
    Oncol Rep; 2006 Oct; 16(4):699-703. PubMed ID: 16969482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FTY720 modulates human oligodendrocyte progenitor process extension and survival.
    Miron VE; Jung CG; Kim HJ; Kennedy TE; Soliven B; Antel JP
    Ann Neurol; 2008 Jan; 63(1):61-71. PubMed ID: 17918267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Nofer JR; Bot M; Brodde M; Taylor PJ; Salm P; Brinkmann V; van Berkel T; Assmann G; Biessen EA
    Circulation; 2007 Jan; 115(4):501-8. PubMed ID: 17242282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chiral vinylphosphonate and phosphonate analogues of the immunosuppressive agent FTY720.
    Lu X; Sun C; Valentine WJ; Shuyu E; Liu J; Tigyi G; Bittman R
    J Org Chem; 2009 Apr; 74(8):3192-5. PubMed ID: 19296586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient T cell accumulation in lymph nodes and sustained lymphopenia in mice treated with FTY720.
    Morris MA; Gibb DR; Picard F; Brinkmann V; Straume M; Ley K
    Eur J Immunol; 2005 Dec; 35(12):3570-80. PubMed ID: 16285007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation of fingolimod (FTY720) in lymphoid tissues contributes to prolonged efficacy.
    Sensken SC; Bode C; Gräler MH
    J Pharmacol Exp Ther; 2009 Mar; 328(3):963-9. PubMed ID: 19074680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunosuppressive effect of S1P1 receptor agonist FTY720].
    Zhou WQ; Zhang HJ; Jin J; Li Y; Li C; Chen XG
    Yao Xue Xue Bao; 2012 Apr; 47(4):546-50. PubMed ID: 22799042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain sphingosine-1-phosphate receptors: implication for FTY720 in the treatment of multiple sclerosis.
    Dev KK; Mullershausen F; Mattes H; Kuhn RR; Bilbe G; Hoyer D; Mir A
    Pharmacol Ther; 2008 Jan; 117(1):77-93. PubMed ID: 17961662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice.
    Keul P; Tölle M; Lucke S; von Wnuck Lipinski K; Heusch G; Schuchardt M; van der Giet M; Levkau B
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):607-13. PubMed ID: 17158351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingosine 1-phosphate receptor agonist FTY720-phosphate causes marginal zone B cell displacement.
    Vora KA; Nichols E; Porter G; Cui Y; Keohane CA; Hajdu R; Hale J; Neway W; Zaller D; Mandala S
    J Leukoc Biol; 2005 Aug; 78(2):471-80. PubMed ID: 15894589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.